Autonomix Medical Inc

For the period ended Mar 31, 2024. Filed May 31, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed May 31, 2024

AMIX$1.85+8.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets as of March 31, 2024 and 2023

Balance Sheets

(in thousands, except par value and share data)	As of
	March 31,
	2024	2023
Assets
Current assets:
Cash	$8,608	$865
Other current assets	783	—
Total current assets	9,391	865
Long-term assets:
Fixed assets, net	16	—
Total long-term assets	16	—
Total Assets	$9,407	$865
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$492	$173
Accrued expenses	285	48
Total current liabilities	777	221
Long-term liabilities:
Long term debt - convertible notes, net of unamortized debt discount	1,002	—
Total long-term liabilities	1,002	—
Total Liabilities	$1,779	$221
Commitments and contingencies (Note 5)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2024, no shares issued and outstanding, and 7,100,000 shares authorized as of March 31, 2023, no shares issued and outstanding	$—	$—
Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2024, 18,846,094 shares issued and outstanding, and 25,000,000 shares authorized as of March 31, 2023, 12,336,571 shares issued and outstanding	19	12
Additional paid-in capital	46,578	24,175
Accumulated deficit	(38,969)	(23,543)
Total Stockholders' Equity	7,628	644
Total Liabilities and Stockholders' Equity	$9,407	$865

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.